Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When is tenofovir alafenamide patent expiring?Lipitor vs generics what's the price gap?What are alcohol's effects on ozempic?When will there be a generic loreev available?How does paclitaxel's binding to albumin change its pharmacokinetics?
See the DrugPatentWatch profile for dupixent
Dupixent’s sales grew from $1.79 billion in 2019 to $4.78 billion in 2020, which is an increase of $2.99 billion. That corresponds to a growth rate of about 167% year over year. [1][2]
The 2019 and 2020 revenue figures used above are reported as Dupixent net product sales in company financial disclosures: $1.79 billion for 2019 and $4.78 billion for 2020. [1][2]
Growth rate = (2020 − 2019) / 2019 = ($4.78B − $1.79B) / $1.79B = $2.99B / $1.79B ≈ 1.67 = 167% [1][2]
The calculation above uses net product sales for Dupixent for 2019 and 2020 as reported in the cited financial disclosures. [1][2] Sources: [1] https://www.sec.gov/ixviewer/documents/20200227x10k.htm [2] https://www.sec.gov/ixviewer/documents/20210301x10k.htm
Other Questions About Dupixent :